Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts

专家展望：健康催化剂从7位分析师的角度来看

Benzinga · 2024/09/20 23:01

7 analysts have shared their evaluations of Health Catalyst (NASDAQ:HCAT) during the recent three months, expressing a mix of bullish and bearish perspectives.

在最近的三个月里，有7位分析师对Health Catalyst（NASDAQ:HCAT）进行了评估，表达了看好和看淡的不同观点。

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。

Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $12.43, a high estimate of $16.00, and a low estimate of $7.00. Highlighting a 2.2% decrease, the current average has fallen from the previous average price target of $12.71.

分析师为Health Catalyst设定了12个月的目标股价，平均目标价为12.43美元，最高估价为16.00美元，最低估价为7.00美元。当前的平均目标价下降了2.2％，从之前的12.71美元的平均目标价下降。

Interpreting Analyst Ratings: A Closer Look...

解读分析师评...

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts

Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts

风险及免责提示

声明